866-997-4948(US-Canada Toll Free)

United States Endometrial Cancer Treatment Market Report 2018

Published By :

QYResearch

Published Date : Jun 2018

Category :

Pharmaceutical

No. of Pages : 97 Pages

In this report, the United States Endometrial Cancer Treatment market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Endometrial Cancer Treatment in these regions, from 2013 to 2025 (forecast).

United States Endometrial Cancer Treatment market competition by top manufacturers/players, with Endometrial Cancer Treatment sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Ariad
Abbott
BD
GlaxoSmithKline
Merck
Novartis
Sanofi
Siemens
Roche

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Chemotherapy
Surgical
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospital
Clinic

Table of Contents

United States Endometrial Cancer Treatment Market Report 2018
1 Endometrial Cancer Treatment Overview
1.1 Product Overview and Scope of Endometrial Cancer Treatment
1.2 Classification of Endometrial Cancer Treatment by Product Category
1.2.1 United States Endometrial Cancer Treatment Market Size (Sales Volume) Comparison by Type (2013-2025)
1.2.2 United States Endometrial Cancer Treatment Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
1.2.3 Chemotherapy
1.2.4 Surgical
1.3 United States Endometrial Cancer Treatment Market by Application/End Users
1.3.1 United States Endometrial Cancer Treatment Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
1.3.2 Hospital
1.3.3 Clinic
1.4 United States Endometrial Cancer Treatment Market by Region
1.4.1 United States Endometrial Cancer Treatment Market Size (Value) Comparison by Region (2013-2025)
1.4.2 The West Endometrial Cancer Treatment Status and Prospect (2013-2025)
1.4.3 Southwest Endometrial Cancer Treatment Status and Prospect (2013-2025)
1.4.4 The Middle Atlantic Endometrial Cancer Treatment Status and Prospect (2013-2025)
1.4.5 New England Endometrial Cancer Treatment Status and Prospect (2013-2025)
1.4.6 The South Endometrial Cancer Treatment Status and Prospect (2013-2025)
1.4.7 The Midwest Endometrial Cancer Treatment Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Endometrial Cancer Treatment (2013-2025)
1.5.1 United States Endometrial Cancer Treatment Sales and Growth Rate (2013-2025)
1.5.2 United States Endometrial Cancer Treatment Revenue and Growth Rate (2013-2025)

2 United States Endometrial Cancer Treatment Market Competition by Players/Suppliers
2.1 United States Endometrial Cancer Treatment Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Endometrial Cancer Treatment Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Endometrial Cancer Treatment Average Price by Players/Suppliers (2013-2018)
2.4 United States Endometrial Cancer Treatment Market Competitive Situation and Trends
2.4.1 United States Endometrial Cancer Treatment Market Concentration Rate
2.4.2 United States Endometrial Cancer Treatment Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Endometrial Cancer Treatment Manufacturing Base Distribution, Sales Area, Product Type

3 United States Endometrial Cancer Treatment Sales (Volume) and Revenue (Value) by Region (2013-2018)
3.1 United States Endometrial Cancer Treatment Sales and Market Share by Region (2013-2018)
3.2 United States Endometrial Cancer Treatment Revenue and Market Share by Region (2013-2018)
3.3 United States Endometrial Cancer Treatment Price by Region (2013-2018)

4 United States Endometrial Cancer Treatment Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)
4.1 United States Endometrial Cancer Treatment Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Endometrial Cancer Treatment Revenue and Market Share by Type (2013-2018)
4.3 United States Endometrial Cancer Treatment Price by Type (2013-2018)
4.4 United States Endometrial Cancer Treatment Sales Growth Rate by Type (2013-2018)

5 United States Endometrial Cancer Treatment Sales (Volume) by Application (2013-2018)
5.1 United States Endometrial Cancer Treatment Sales and Market Share by Application (2013-2018)
5.2 United States Endometrial Cancer Treatment Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 United States Endometrial Cancer Treatment Players/Suppliers Profiles and Sales Data
6.1 Ariad
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Endometrial Cancer Treatment Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Ariad Endometrial Cancer Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Main Business/Business Overview
6.2 Abbott
6.2.2 Endometrial Cancer Treatment Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Abbott Endometrial Cancer Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Main Business/Business Overview
6.3 BD
6.3.2 Endometrial Cancer Treatment Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 BD Endometrial Cancer Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
6.3.4 Main Business/Business Overview
6.4 GlaxoSmithKline
6.4.2 Endometrial Cancer Treatment Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 GlaxoSmithKline Endometrial Cancer Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
6.4.4 Main Business/Business Overview
6.5 Merck
6.5.2 Endometrial Cancer Treatment Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Merck Endometrial Cancer Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
6.5.4 Main Business/Business Overview
6.6 Novartis
6.6.2 Endometrial Cancer Treatment Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Novartis Endometrial Cancer Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Main Business/Business Overview
6.7 Sanofi
6.7.2 Endometrial Cancer Treatment Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Sanofi Endometrial Cancer Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
6.7.4 Main Business/Business Overview
6.8 Siemens
6.8.2 Endometrial Cancer Treatment Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Siemens Endometrial Cancer Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
6.8.4 Main Business/Business Overview
6.9 Roche
6.9.2 Endometrial Cancer Treatment Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Roche Endometrial Cancer Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
6.9.4 Main Business/Business Overview

7 Endometrial Cancer Treatment Manufacturing Cost Analysis
7.1 Endometrial Cancer Treatment Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Endometrial Cancer Treatment

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Endometrial Cancer Treatment Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Endometrial Cancer Treatment Major Manufacturers in 2017
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Endometrial Cancer Treatment Market Size (Value and Volume) Forecast (2018-2025)
11.1 United States Endometrial Cancer Treatment Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Endometrial Cancer Treatment Sales Volume Forecast by Type (2018-2025)
11.3 United States Endometrial Cancer Treatment Sales Volume Forecast by Application (2018-2025)
11.4 United States Endometrial Cancer Treatment Sales Volume Forecast by Region (2018-2025)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer

List of Table

List of Tables and Figures

Figure Product Picture of Endometrial Cancer Treatment
Figure United States Endometrial Cancer Treatment Market Size (K Units) by Type (2013-2025)
Figure United States Endometrial Cancer Treatment Sales Volume Market Share by Type (Product Category) in 2017
Figure Chemotherapy Product Picture
Figure Surgical Product Picture
Figure United States Endometrial Cancer Treatment Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Endometrial Cancer Treatment by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure United States Endometrial Cancer Treatment Market Size (Million USD) by Region (2013-2025)
Figure The West Endometrial Cancer Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Endometrial Cancer Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Endometrial Cancer Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Endometrial Cancer Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Endometrial Cancer Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Endometrial Cancer Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Endometrial Cancer Treatment Sales (K Units) and Growth Rate (2013-2025)
Figure United States Endometrial Cancer Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Endometrial Cancer Treatment Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Endometrial Cancer Treatment Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Endometrial Cancer Treatment Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Endometrial Cancer Treatment Sales Share by Players/Suppliers
Figure 2017 United States Endometrial Cancer Treatment Sales Share by Players/Suppliers
Figure United States Endometrial Cancer Treatment Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Endometrial Cancer Treatment Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Endometrial Cancer Treatment Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Endometrial Cancer Treatment Revenue Share by Players/Suppliers
Figure 2017 United States Endometrial Cancer Treatment Revenue Share by Players/Suppliers
Table United States Market Endometrial Cancer Treatment Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Endometrial Cancer Treatment Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Endometrial Cancer Treatment Market Share of Top 3 Players/Suppliers
Figure United States Endometrial Cancer Treatment Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Endometrial Cancer Treatment Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Endometrial Cancer Treatment Product Category
Table United States Endometrial Cancer Treatment Sales (K Units) by Region (2013-2018)
Table United States Endometrial Cancer Treatment Sales Share by Region (2013-2018)
Figure United States Endometrial Cancer Treatment Sales Share by Region (2013-2018)
Figure United States Endometrial Cancer Treatment Sales Market Share by Region in 2017
Table United States Endometrial Cancer Treatment Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Endometrial Cancer Treatment Revenue Share by Region (2013-2018)
Figure United States Endometrial Cancer Treatment Revenue Market Share by Region (2013-2018)
Figure United States Endometrial Cancer Treatment Revenue Market Share by Region in 2017
Table United States Endometrial Cancer Treatment Price (USD/Unit) by Region (2013-2018)
Table United States Endometrial Cancer Treatment Sales (K Units) by Type (2013-2018)
Table United States Endometrial Cancer Treatment Sales Share by Type (2013-2018)
Figure United States Endometrial Cancer Treatment Sales Share by Type (2013-2018)
Figure United States Endometrial Cancer Treatment Sales Market Share by Type in 2017
Table United States Endometrial Cancer Treatment Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Endometrial Cancer Treatment Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Endometrial Cancer Treatment by Type (2013-2018)
Figure Revenue Market Share of Endometrial Cancer Treatment by Type in 2017
Table United States Endometrial Cancer Treatment Price (USD/Unit) by Types (2013-2018)
Figure United States Endometrial Cancer Treatment Sales Growth Rate by Type (2013-2018)
Table United States Endometrial Cancer Treatment Sales (K Units) by Application (2013-2018)
Table United States Endometrial Cancer Treatment Sales Market Share by Application (2013-2018)
Figure United States Endometrial Cancer Treatment Sales Market Share by Application (2013-2018)
Figure United States Endometrial Cancer Treatment Sales Market Share by Application in 2017
Table United States Endometrial Cancer Treatment Sales Growth Rate by Application (2013-2018)
Figure United States Endometrial Cancer Treatment Sales Growth Rate by Application (2013-2018)
Table Ariad Basic Information List
Table Ariad Endometrial Cancer Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Ariad Endometrial Cancer Treatment Sales Growth Rate (2013-2018)
Figure Ariad Endometrial Cancer Treatment Sales Market Share in United States (2013-2018)
Figure Ariad Endometrial Cancer Treatment Revenue Market Share in United States (2013-2018)
Table Abbott Basic Information List
Table Abbott Endometrial Cancer Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Abbott Endometrial Cancer Treatment Sales Growth Rate (2013-2018)
Figure Abbott Endometrial Cancer Treatment Sales Market Share in United States (2013-2018)
Figure Abbott Endometrial Cancer Treatment Revenue Market Share in United States (2013-2018)
Table BD Basic Information List
Table BD Endometrial Cancer Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure BD Endometrial Cancer Treatment Sales Growth Rate (2013-2018)
Figure BD Endometrial Cancer Treatment Sales Market Share in United States (2013-2018)
Figure BD Endometrial Cancer Treatment Revenue Market Share in United States (2013-2018)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Endometrial Cancer Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure GlaxoSmithKline Endometrial Cancer Treatment Sales Growth Rate (2013-2018)
Figure GlaxoSmithKline Endometrial Cancer Treatment Sales Market Share in United States (2013-2018)
Figure GlaxoSmithKline Endometrial Cancer Treatment Revenue Market Share in United States (2013-2018)
Table Merck Basic Information List
Table Merck Endometrial Cancer Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Merck Endometrial Cancer Treatment Sales Growth Rate (2013-2018)
Figure Merck Endometrial Cancer Treatment Sales Market Share in United States (2013-2018)
Figure Merck Endometrial Cancer Treatment Revenue Market Share in United States (2013-2018)
Table Novartis Basic Information List
Table Novartis Endometrial Cancer Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis Endometrial Cancer Treatment Sales Growth Rate (2013-2018)
Figure Novartis Endometrial Cancer Treatment Sales Market Share in United States (2013-2018)
Figure Novartis Endometrial Cancer Treatment Revenue Market Share in United States (2013-2018)
Table Sanofi Basic Information List
Table Sanofi Endometrial Cancer Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sanofi Endometrial Cancer Treatment Sales Growth Rate (2013-2018)
Figure Sanofi Endometrial Cancer Treatment Sales Market Share in United States (2013-2018)
Figure Sanofi Endometrial Cancer Treatment Revenue Market Share in United States (2013-2018)
Table Siemens Basic Information List
Table Siemens Endometrial Cancer Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Siemens Endometrial Cancer Treatment Sales Growth Rate (2013-2018)
Figure Siemens Endometrial Cancer Treatment Sales Market Share in United States (2013-2018)
Figure Siemens Endometrial Cancer Treatment Revenue Market Share in United States (2013-2018)
Table Roche Basic Information List
Table Roche Endometrial Cancer Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Roche Endometrial Cancer Treatment Sales Growth Rate (2013-2018)
Figure Roche Endometrial Cancer Treatment Sales Market Share in United States (2013-2018)
Figure Roche Endometrial Cancer Treatment Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Endometrial Cancer Treatment
Figure Manufacturing Process Analysis of Endometrial Cancer Treatment
Figure Endometrial Cancer Treatment Industrial Chain Analysis
Table Raw Materials Sources of Endometrial Cancer Treatment Major Players/Suppliers in 2017
Table Major Buyers of Endometrial Cancer Treatment
Table Distributors/Traders List
Figure United States Endometrial Cancer Treatment Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Endometrial Cancer Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Endometrial Cancer Treatment Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Endometrial Cancer Treatment Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Endometrial Cancer Treatment Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Endometrial Cancer Treatment Sales Volume (K Units) Forecast by Type in 2025
Table United States Endometrial Cancer Treatment Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Endometrial Cancer Treatment Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Endometrial Cancer Treatment Sales Volume (K Units) Forecast by Application in 2025
Table United States Endometrial Cancer Treatment Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Endometrial Cancer Treatment Sales Volume Share Forecast by Region (2018-2025)
Figure United States Endometrial Cancer Treatment Sales Volume Share Forecast by Region (2018-2025)
Figure United States Endometrial Cancer Treatment Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *